1 unchanged sentence
Insider Trading Arrangements
−Removed: During the three months ended June 30, 2024, none of our directors or executive officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
−Removed: Entry into a Material Definitive Agreement
−Removed: On July 30, 2024, we entered into a new Office Lease (the “Agreement”) with RFL No.
−Removed: 4 Limited Partnership for our existing 25,000 square-foot office space in The Woodlands, Texas.
−Removed: The term of the new lease begins on September 1, 2025 and extends through January 1, 2031, providing for escalating yearly base rent payments starting at $773,724 and increasing to $875,398 in the final year of the lease.
−Removed: The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement filed as an exhibit hereto.
−Removed: 3.1 — Sixth Amended and Restated Certificate of Incorporation (filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K dated May 10, 2024 and incorporated by reference herein).
−Removed: 10.1 — Sixth Amendment to Loan and Security Agreement, dated June 28, 2024, with Oxford Finance, LLC and the lenders listed therein (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K dated June 28, 2024 and incorporated by reference herein).
−Removed: 10.2 — Offer Letter, dated July 3, 2024, with Michael S.
−Removed: (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K dated July 3, 2024 and incorporated by reference herein).
−Removed: *10.3 — Office Lease , dated July 30, 2024, with RFL No.
−Removed: 4 Limited Partnership
+Added: During the three months ended September 30, 2024, none of our directors or executive officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: 10.1 — Separation Agreement, dated September 13, 2024, with Jeffrey L.
+Added: Wade (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K dated September 13, 2024 and incorporated by reference herein).
+Added: 10.2 — Consulting Agreement, dated September 13, 2024, with Jeffrey L.
+Added: Wade (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K dated September 13, 2024 and incorporated by reference herein).
— Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
12 unchanged sentences
Lexicon Pharmaceuticals, Inc.
−Removed: August 2, 2024 By:
+Added: November 13, 2024 By:
/s/ Michael S.
Chief Executive Officer
−Removed: August 2, 2024 By:
−Removed: /s/ Jeffrey L.
−Removed: President and Chief Operating Officer
+Added: November 13, 2024 By:
+Added: /s/ Kristen L.
+Added: Vice President, Finance and Accounting
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.